Alta Partners discloses 7.7% BioRestorative (BRTX) ownership stake

Rhea-AI Filing Summary

Alta Partners LLC has filed a Schedule 13G reporting a significant passive ownership position in BioRestorative Therapies, Inc. common stock. Alta Partners beneficially owns 1,787,163 shares, representing 7.7% of the company’s outstanding common stock.

Alta Partners reports sole voting and dispositive power over all 1,787,163 shares and no shared power. The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of BioRestorative Therapies.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

BioRestorative Therapies, Inc.

(Name of Issuer)

Common Stock, $0.0001 par value

(Title of Class of Securities)

090655606

(CUSIP Number)

02/13/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 090655606

1

Names of Reporting Persons

Alta Partners LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

NEW YORK

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,787,163.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 1,787,163.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,787,163.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

7.7 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: BioRestorative Therapies, Inc.
(b)	Address of issuer's principal executive offices: 40 MARCUS DRIVE, MELVILLE, NEW YORK, 11747.
Item 2.
(a)	Name of person filing: Alta Partners LLC
(b)	Address or principal business office or, if none, residence: 1205 Franklin Avenue Garden City, New York 11530
(c)	Citizenship: New York Limited Liability Company
(d)	Title of class of securities: Common Stock, $0.0001 par value
(e)	CUSIP No.: 090655606
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 1,787,163 shares, excluding shares underlying warrants which are not exercisable.
(b)	Percent of class: 7.7%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 1,787,163 shares
	(ii) Shared power to vote or to direct the vote: 0 shares
	(iii) Sole power to dispose or to direct the disposition of: 1,787,163 shares
	(iv) Shared power to dispose or to direct the disposition of: 0 shares
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Alta Partners LLC

Signature:	/s/ Steven Cohen
Name/Title:	Steven Cohen, Managing Member
Date:	02/13/2026

FAQ

What stake does Alta Partners LLC report in BioRestorative Therapies (BRTX)?

Alta Partners LLC reports beneficial ownership of 1,787,163 shares of BioRestorative Therapies common stock, representing 7.7% of the class. This indicates Alta Partners holds a sizable minority position but not a controlling interest in the company’s equity.

Is Alta Partners’ BioRestorative (BRTX) position reported as passive or active?

Alta Partners certifies the BioRestorative position as passive. The filing states the shares were acquired and are held in the ordinary course of business, not to change or influence control or to participate in transactions with that purpose or effect.

How many BioRestorative (BRTX) shares does Alta Partners control the voting for?

Alta Partners reports sole voting power over 1,787,163 BioRestorative common shares and no shared voting power. It also has sole dispositive power over the same number of shares, meaning it alone can decide how these shares are voted and whether to sell them.

Why did Alta Partners LLC have to file a Schedule 13G for BRTX?

A Schedule 13G is required when an investor exceeds 5% ownership of a company’s registered equity. Alta Partners reached 7.7% of BioRestorative’s common stock, triggering this beneficial ownership disclosure under U.S. securities rules as a passive holder.

Does Alta Partners’ 13G filing mention any warrants in BioRestorative (BRTX)?

Yes. Alta Partners states it beneficially owns 1,787,163 shares of common stock, excluding shares underlying warrants that are not exercisable. The reported ownership percentage therefore reflects only currently exercisable or outstanding common shares, not potential warrant shares.

Who signed the Alta Partners ownership report for BioRestorative (BRTX)?

The Schedule 13G is signed by Steven Cohen as Managing Member of Alta Partners LLC. The signature certifies, after reasonable inquiry, that the information on Alta Partners’ beneficial ownership of BioRestorative shares is true, complete, and correct as of the stated date.